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ABSTRACT 
 
Expression Analysis of BB0174, A Membrane Protein of Borrelia burgdorferi, the 
Causative Agent of Lyme Disease. (May 2012) 
 
Joseph James Modarelli II 
Department of Veterinary Pathobiology 
Texas A&M University 
 
Research Advisor: Dr. Maria Esteve-Gassent 
Department of Veterinary Pathobiology 
 
Borrelia burgdorferi (Bb), the causative agent of Lyme disease, is a spirochetal pathogen 
that colonizes mammalian hosts causing numerous neurological and physiological 
symptoms. This thesis focuses on the gene expression of BB0174, a membrane protein 
of Bb. Gene expression in Bb is dependent on many environmental signals following 
transmission from tick to host. The analysis of BB0174 shows high in silico similarities 
with the typical membrane associated histidine kinases of a Two-component system 
(TCS) for signal transduction. Thus this study will determine whether changes in 
temperature and pH conditions will induce changes in the levels of mRNA and protein 
of BB0174 in Bb. RNA will be purified from Bb growing at differing pH and 
temperature conditions similar to those found in the unfed tick and again from the fed 
tick. cDNA will then be generated and PCR analysis using specific primers for bb0174 
and neighboring regions will be conducted. The BB0174 protein levels will also be 
evaluated after growing Bb at room temperature and shifted to 37ºC. This project will 
allow us to determine whether or not BB0174 is in fact one of the members of a novel 
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TCS, and thus further our understanding of the mechanisms orchestrating gene 
expression in Bb. Taken together, out studies showed that bb0174-bb0175 are not part of 
a new Two component system and that both are expressed under growth conditions that 
mimic the fed tick conditions (37ºC/pH6.8). 
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NOMENCLATURE 
 
LD Lyme Disease 
Bb Borrelia burgdorferi 
TCS Two-Component System 
HK Histidine Kinase 
RR Response Regulator 
PCR Polymerase Chain Reaction 
RT Room Temperature (23ºC-25ºC) 
Rxn Reaction 
Amp100 Ampicillin 100µg/ml 
Kan50 Kanamycin 50µg/ml 
Can20 Chloramphenicol 20µg/ml 
IPTG Isopropyl β-D-1-thiogalactopyranoside 
PASN Post Absorption Supernatants 
2x FSB 2X Final Sample Buffer 
BSA Bovine Serum Albumine 
TBS Tris Buffer Saline 
RTSB Reverse Transcriptase Buffer 
Tm Melting Temperature 
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CHAPTER I 
INTRODUCTION 
 
Lyme disease (LD) is the most prevalent tick borne disease in the US with a total of 
22,572 confirmed human cases reported to CDC in 2010. LD in the US is caused by the 
infection of a mammalian host with the bacterium Borrelia burgdorferi (Bb) sensu 
stricto acquired through the bite of an infected Ixodes ticks (2, 14, 26). B. burgdorferi 
sensu stricto is part of the B. burgdorferi sensu lato complex. Within this complex B. 
afzelii and B. garnii are the causative agents of LD in Europe and Asia together with 12 
more genospecies (13, 18, 22). In addition, different Ixodes ticks will transmit the 
different Borrelia species. In this case, B. burgdorferi sensu stricto will be transmitted by 
I. scapularis in East US, I. pacificus in West US. I. ricinus and I. persulcatus will be the 
competent vector for the transmission of LD in Euroasia. Ixodes scapularis, or deer 
ticks, is more active during their nymphal stage, where infection of a host is more 
prevalent. Figure 1, describes the transmission of Bb, and the life cycle of Ixodes 
scapularis. Rodents, along with other various animals, play an important role as 
reservoir hosts, transferring Bb to the tick during its blood meal (7). 
A significant increase in the number of reported cases has been observed in the past few 
years, classifying Lyme disease as a re-emerging infection. Lyme borreliosis is, 
therefore, an important public health issue particularly in endemic areas. According to 
                                                
• This thesis follows the style of Journal of Infection and Immunity. 
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the CDC, LD has surpassed AIDS as one of the fastest growing infectious epidemics in 
the US, with a cost to society measured at approximately $1 billion annuallyA.  
 
 
 
 
 
                                                
A http://teenswithlyme.webs.com/statistics.htm 
 
 
FIG 1: Lyme Disease Transmission Cycle. Eggs laid by an adult female deer tick in the spring hatch 
into larvae within a couple months. The larva will then locate a blood meal, Host 1, where if already 
affected with LD, will transmit the bacterium Bb to the larva. After feeding, the larvae will drop off 
Host 1, and proceed to molt into a nymph in fall months, and then remain inactive throughout the winter 
until early May, where nymphal activity begins. The nymph will now attach unto Host 2 (note human 
presence), and if previously infected with the LD spirochete, will transfer the bacterium to Host 2. Once 
engorged from its blood meal, the nymph will remove itself from Host 2 and molt into an adult, 
remaining active throughout the fall, awaiting the presence of Host 3. Mating may take place on or off 
the host, resulting in a gravid female, who around spring months, will detach from Host 3 and lay eggs 
underneath leaf litter and die. The eggs hatch later in the summer, beginning the two-year cycle. 
Figure based on design by Erin McGregor. 
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Bb is a spirochete bacterium that invades the blood and tissues of various mammals, 
mostly humans, dogs and horses. LD occurs as a multi-systemic disorder leading to 
carditis (10% of untreated adults), arthritis (60% of the cases) and other neurological and 
physiological symptoms. Erythema migrans, a “bullseye” shaped rash, is the only 
manifestation of LD that is sufficiently distinctive to allow clinical diagnosis in the 
absence of laboratory confirmation. However, the presence of an erythema migrans is 
only found in a small number of LD associated cases, making clinical diagnosis rare in 
patients affected by LD (1, 18, 23). Furthermore, there is very little information available 
on the tissue-specific, host pathogen interactions that lead to the pathological 
manifestations of infection with Bb. 
 
The ability of this spirochetal pathogen to colonize mammals is dependent on its ability 
to rapidly alter gene expression in response to highly disparate environmental signals 
following transmission from infected ticks. This type of response is very much 
dependent on the presence of a robust signal transduction system that can induce change 
in gene expression (9, 12). In bacteria, the signal transduction relays on Two-component 
systems (TCS) (9). TCS typically consist of a membrane associated histidine kinase 
(HK) and a response regulator (RR). 
 
Phosphotransfer-mediated signaling pathways allow cells to sense and respond to 
environmental stimuli (24). Typically the signal transduction starts by the 
autophosphorilation of a histidine residue in the HK upon sensing an environmental 
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signal. The phosphoryl group will be transferred to the RR, which will bind to DNA, 
RNA or a protein to regulate gene expression. Bb has only 2 TCS described so far 
(Hpk1-Rrp1 and Hph2-Rrp2) (17) while other bacterial species such as E. coli have an 
average 52 TCS (12).  
 
Our hypothesis is that Bb might have other TCS that will be regulating gene expression 
upon recognition of different stimuli when this bacterium travels from the tick to the 
mammalian host. One of the candidates to be part of a TCS is BB0174. This protein has 
a signal peptide in the N-terminus, a transmembrane domain in the center of the protein 
and a phosphorylation site (H180) in the C-terminus of the protein (Figure 2) and it is a 
protein of unknown function. Furthermore, upstream of BB0174 it is encoded BB0175 
that has a phosphorylation site in amino acids 176-179 (KKRS) and it is also a protein of 
unknown function. Thus these two proteins shall be considered for functioning as an 
operon in Bb, where their expression may be as a single transcript or not at all. 
 
 
Consequently, the main objective of this proposal is to determine the conditions at which 
BB0174, a membrane protein of Borrelia burgdorferi is expressed. We will be 
experimenting with two types of DNA extracted from B. burgdorferi B31 clonal 
derivative MSK5. Moreover, the presence of an operon comprising BB0174-BB0175 
will also be evaluated by means of PCR analysis. This will help understanding whether 
BB0174 and BB0175 could be part of a novel TCS in B. burgdorferi, setting the basis 
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for further research identifying the mechanism by which this system regulates the gene 
expression in the causative agent of Lyme disease.  
  
FIG 2: bb0174 Chromosomal Region. (A) Chromosome region where bb0174 and bb0175 are encoded. 
(B) Structural components of BB0174: the signal peptide comprises amino acids 1-18, with cleavage 
site in between amino acid 18-19 (LYS-YE), transmembrane domain extends from amino acid 138 to 
160, the hypothetical histidine for autophosphorilation is in position 180. Consequently the amino acids 
19-137 are exposed to the outside, while amino acids 161 through 302 are inside the cell. 
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CHAPTER II 
METHODS 
 
Cloning bb0174 into pCR®2.1 TOPO® 
In order to work with the gene of interest we cloned it in the commercially available 
cloning vector pCR®2.1 TOPO® (InvitrogenTM). To do so we followed the steps 
described bellow. 
 
 
 
PCR amplification and cloning steps 
The bb0174 gene without the first 78 nucleotides (encoding for the signal peptide) was 
amplified by PCR using B. burgdorferi B31 template genomic DNA and primers with 
engineered restriction enzyme sites for NdeI (forward) and XhoI (reverse). The PCR 
reaction protocol was: 94°C for one minute, followed by 30 cycles of 94ºC for one 
minute, annealing at 45°C for one minute, and amplification at 72°C for three minutes 
and a final 4°C (TABLE 1). Amplicons were confirmed by running a 0.8% agarose gel 
TABLE 1: PCR Reaction (Ex Taq). Illustrates “recipe” for PCR reaction 
(Takara). 
 
 1 rxn 
10x buffer 2.500 µl 
10x dNTP 2.500 µl 
Primer Mix 2.000 µl 
Ex Taq polymerase 0.125 µl 
DNA 2.000 µl 
ddH20 15.875 µl 
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at 100 volts for 45 minutes. Positive PCR products were cloned into pCR®2.1 TOPO® 
vector following manufactures recommendations. Briefly, 4µl of the PCR product were 
incubated with 1µl of the vector at room temperature (RT) over night. Final reaction was 
transformed into TOP10 Component cells (InvitrogenTM) by electroporation 
(Electroporator 2510 Eppendorf) at, 25µF capacitor, 2.5kV, and the Pulse Controller 
Unit to 200Ω). Cells were recovered in SOC media for one hour at 37ºC. Positive clones 
were selected overnight at 37ºC on LB agar plates containing 100µg/ml of Ampicillin 
(Amp100) and 50µg/ml of Kanamycin (Kan50), 40µg X-Gal and 1mM IPTG. Twelve 
positive colonies were inoculated in LB broth with Amp100 and Kan50 and incubated 
overnight at 37ºC for further analysis. 
 
 
 
TABLE 2: EPB Recipe. This recipe makes 50ml of Easy Prep Buffer (EPB). One-milliliter 
aliquots were stored at -20ºC. 
 
1M Tris pH8 500 µl 
0.5M EDTA pH 8 100 µl 
Sucrose 6.500 g 
Lysozyme  0.100 g 
Pancreatic 
RNase  
0.005 g 
BSA  0.005 g  
 
 
TABLE 3: EcoRI Reaction. 
 
 1 rxn 
10 x buffer 2.0 µl 
EcoR1 0.5 µl 
DNA 10.0 µl 
ddH20 7.5 µl 
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Confirmation of positive clones 
Cells from overnight cultures were harvested by centrifugation at 10,000 rpm for four 
minutes. Pellets were re-suspended in easy prep buffer (EPB) (TABLE 2) followed by 
boiling for one minute and centrifuging at 12000rpm for 15 minutes. The supernatants 
were used in the digestion reaction with EcoRI enzyme at 37ºC for 90 minutes (TABLE 
3). Positive clones (PCR 2.1 bb0174) were saved at -80ºC for further use. 
 
 
 
 
 
Expression of rBB0174 
Cloning of bb0172 in the expression vector pET23a. 
In order to express recombinant BB0174, bb0174 cloned in pCR®2.1 and the pET23a 
expression vector (Novagen ®) were digested with NdeI and XhoI (New England 
Biolabs) restriction enzymes respectively at 37ºC for two hours (TABLE 4). Digestion 
products were separated in a 0.8% agarose gels. Bands corresponding with digested 
bb0174 and pET23a were excised and DNA extracted using the Gel and PCR Clean up 
TABLE 4: Recipe for Nde1 and Xho1. 
 
* = 10 x buffer #4 
 
 1 rxn 
10 x buffer* 4.0 µl 
Nde1 3.0 µl 
Xho1 3.0 µl 
BSA 0.4 µl 
DNA 25 µl 
ddH2O 3.6 µl 
 
  9 
kit by Promega following manufacturer’s recommendations. DNA was eluted in 30µl of 
ultraclean water and used in the ligation reaction specified in TABLE 5 overnight at 
16ºC. After ligation was completed DNA was cleaned by ethanol precipitation, air-dried 
and re-suspended in 20µl of ultrapure water. Two µl of the clean ligation reaction was 
used to transform TOP10 cells using the same electroporation and recovery protocols 
described above. Positive clones were selected on LB agar plates containing Amp100 
following the same screening process described in the previous section. In this case, 
positive clones were confirmed by digestion with NdeI and XhoI as well as by 
sequencing reactions.  
 
 
 
 
 
Sequencing reaction 
Positive clones for pET23a(bb0174) by restriction digestion were grown overnight and 
plasmidic DNA extracted using the PureYield™ Plasmid Miniprep System (Promega). 
Ten µl of each clone were submitted for sequencing (Eton Biosciencies) utilizing 
specific primers to the T7 Promoter and T7 Terminator under which bb0174 was cloned 
TABLE 5: Ligation Reaction. Recipe for Ligation 
reaction using Promega T4 DNA Ligase. 
 
 1 rxn 
10 x buffer* 2 µl 
Insert (bb0174) 10 µl 
Vector (pET23a) 5 µl 
T4 DNA ligase 1 µl 
H2O 2 µl 
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in pET23a. Results were analyzed using the MacVector computer program (MacVector, 
Inc.) to determine whether bb0174 was in frame with the promoter, the histidine tag and 
the terminator sequence.  
Transformation into Rosetta® component cells 
DNA from the positive pET23a(bb0174) was electroporated into the expression E. coli 
strain Rosetta® using the conditions described above. After recuperating the transformed 
cells in SOC for one hour at 37ºC, they were plated on LB agar containing Amp100, and 
chloramphenicol 20µg/ml (Can20) at 37ºC overnight. Two colonies were picked, 
incubated at 37ºC overnight, and used for a small-scale induction to check conditions at 
which the protein was expressed. Positive clones were stored at -80ºC for further use. 
Expression and purification of rBB0174 
The first step to purify the rBB0174 was to induce their expression in E. coli. To this 
end, a culture of the E. coli strain RosettaTM expressing rBB0174 was started in LB broth 
media containing Amp100 and Can20 at 37ºC, shaking overnight.  A 1:100 dilution of 
each of the cultures was used to start one liter of LB Broth containing Amp100 and Can20. 
Large cultures were shaken for 4-5 hours at 37ºC or until OD600nm=0.5 to 0.8.  When 
cultures reached the right bacterial density, BB0174 expression was induced by adding 
1ml of Isopropyl β-D-1-thiogalactopyranoside (IPTG) and incubated for 2 hours at 37°C 
with continuous shaking. After the two hour induction, cells were harvested by 
centrifugation for 20 minutes at 4000rpm and 4ºC. Pellets were stored at -80°C until use. 
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Protein purification 
After thawing on ice the pellets of RosettaTM cells expressing the rBB0174, 25ml of 
Lysis Buffer (50mM sodium phosphate, 8M urea, 300mM NaCl, 20mM imidazole pH 
7.4) were added to re-suspend the cells.  Cells were disrupted by French press (Thermo 
scientific) three times to ensure complete lysis. Lysates were centrifuged for 20 minutes 
at 4000rpm and 4ºC to eliminate cell debris.  The pellet was saved at -80°C until 
purification of the protein was confirmed. Supernatants were mixed with 5ml of Nickel 
beads (His60 SuperflowTM resin, Chlontech) previously equilibrated with Wash Buffer 
(50mM sodium phosphate, 8M urea, 300mM NaCl, 40mM imidazole pH 7.4) and 
incubated overnight at 4°C with continuous gentle shacking.  After the overnight 
binding, beads were clean by centrifugation for five minutes at 500 rpm and 4ºC to 
remove any unspecific protein binding. Post absorption supernatants (PASN) and 
washing fraction were saved at -80ºC until purification of the recombinant protein was 
confirmed. Beads with the recombinant His tag containing proteins were allowed to pack 
at room temperature in a chromatography column (BioRad). While the beads settle, two 
sets of 25 elution collection tubes were prepared. BB0174 was eluted by adding 10ml of 
the elution buffer (50mM sodium phosphate, 8M urea, 300mM NaCl, 300mM imidazole 
pH 7.4) to the column. Approximately 20ml of elution buffer is needed to ensure the 
adequate purification of the recombinant proteins. Fifty µl of each elution fraction was 
combined with 50µl of 2X Final Sample Buffer (2x FSB) to check for the faction in 
whom the recombinant protein gets purified.  Elution fractions were saved at -80°C until 
use to immunize chickens to generate specific antibodies (IgY). 
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SDS-PAGE gel 
In order to determine in which elution fractions the rBB0174 was mostly present, an 
aliquot of the induction pellet, PASN, wash fractions and each of the elution fractions 
were separated in a 12% SDS-PAGE gel. Gels were stained in Coomassiee Blue (0.25% 
coomassiee brilliant blue dye R250, 45% methanol, 10% acetic). After destaining (45% 
methanol, 10% acetic acid), the more concentrated elution fractions were selected and 
prepared for purification. The gels were stored (10% ethanol, 5% glycerol) and dried for 
further reference. 
Protein clean up and concentration 
The fractions containing BB0174 were cleaned and concentrated by using the Amicon 
filtration system (Millipore) with cut off pores of 3kDa or 5kDa to ensure the retention 
of the protein of interest (30kDa). The concentrated protein was further cleaned by 
dialysis to ensure the elimination of the denaturing agent Urea and the Imidazol used to 
elute the protein during the purification steps. To this end, the fractions being cleaned 
are placed in a dialysis cassette (Slide-A-Lyser® Cassette, Thermos Scientific) and in 
500ml of dialysis buffer (50mM sodium phosphate, 300mM NaCl) for two hours at RT 
and continuous stirring with buffer changed every hour, followed by an overnight 
dialysis with fresh buffer at 4ºC. After dialysis, the concentrated fractions were 
recovered and stored at -80°C. Aliquots were used to determine protein concentration. 
Protein quantification 
Protein concentration was determined by using the Pierce BSA Assay Kit (Thermo 
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Scientific) so as to adjust the protein needed to immunize laying hens. Briefly, BSA 
(Bovine Serum Albumin) protein standards were made with concentrations ranging from 
0 to 250µg/ml.  The test protein was diluted 1:5 and 1:10 and 25µL of each protein 
dilutions and standards were placed in triplicates in a 96 well plate (Corning). After 
adding 200µl of the Working reagent (following manufacturer’s recommendations) 
plates were incubated for 30 minutes at 37ºC and in the dark. After incubation, protein 
concentration was measured in a plate reader (BGI LABTECH OMEGA). 
Generation of specific BB0174 antibodies 
In order to determine the conditions at which bb0174 expresses in Bb, we will analyze 
not only its RNA levels but also those of the BB0174 protein by immunoblot assay after 
growing Bb under different conditions. To this end we need specific antibodies that were 
generated in-house utilizing the laying hens model currently in use in our laboratory to 
generate specific antibodies towards borrelial proteins. Briefly, we immunized two 
laying hens with 50µg of rBB0174 per hen at days 0, 14 and 21. TiterMaxTM (Sigma-
Aldrich) was used as adjuvant during the whole immunization protocol (v:v). After day 
28 none-fertilized eggs were collected and the specific IgY was purified. 
Purification of specific BB0174 IgG (IgY) 
To extract the IgG (IgY) from none-fertilized eggs, we collected them after day 28 of the 
immunization protocol described above. In this case, we collected eggs from days 30, 34 
and 38. Eggs were stored at -20ºC to help during the separation of the egg yolk (where 
the IgY is located) from the albumin present in the egg white. Eggs were thawed and the 
  14 
albumin was separated from the egg yolk. The egg yolks were pooled and re-suspended 
in 300ml of sterile ultrapure water. To dilapidate the yolk pH was adjusted to 7 and 
stored overnight at -20ºC. After thawing the yolk emulsification, lipids were separated 
by centrifugation at 4000rpm for 20 minutes ant 4ºC. Supernatants were collected and 
the pH was re-adjusted to 7.6. Finally the IgY was desalted out with (NH4)2SO4 stirring 
for one hour at RT, re-suspended in Tris buffer saline (TBS) aliquoted and stored at -
20ºC until use.  
Expression of bb0174 and bb0175 in B. burgdorferi B31 
In order to determine under which conditions bb0174 and bb0175 were expressed so as 
to determine the presence of an operon, we followed the methodologies described below.  
B. burgdorferi B31 bacterial cultures 
B. burgdorferi B31 strain MSK5 was grown in BSK-II medium complemented with 6% 
inactivated rabbit serum at RT at pH 7.6 in order to mimic the unfed tick conditions. 
After bacterial cultures reached a cell density of 5*107cells/ml a subculture was started 
at 5*105cells/ml density at 37ºC pH 6.8 so as to mimic the tick feeding conditions.  
When bacterial cultures reached a cell density of 5*107cells/ml (either at RT or at 37ºC), 
spirochetal cells were harvested by centrifugation for 20 minutes at 4000rpm and 4ºC 
and subsequently washed in HBSS. Cells pellets were used for RNA extractions.  
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RNA extraction 
To isolate the RNA from the Bb bacterium the RiboPureTM-Bacteria Kit protocol 
(Applied Biosystems) was utilized following manufacture’s instructions with slight 
modifications to optimize yields. Briefly, Bb cultures growing at RT or 37ºC were 
harvested as described above and pellets resuspended in 200µl of HBSS. To lyse the 
cells 400µl of RNAwiz were added and the mix was vigorously vortexed. After ensure 
complete mixing of the cells with the phenol reagent, 250µl of chloroform was added 
and incubated at RT for 10 minutes with mixing every 2 minutes. To separate the 
aqueous from the organic phase, lysates were centrifuged for five minute at 10,000rpm 
and 4ºC. The aqueous phase was collected and mixed with 0.5 volumes of 100% ethanol. 
At this point the RNA was purified by using manufacturer’s recommendations. RNA 
was eluted in a total of 60µl of elution buffer. RNA extraction was treated with DNase 
for 30minutes at 37ºC as recommended by the manufacturer in order to eliminate any 
DNA contamination in the purification sample. DNase reaction was stopped by 
incubating for 2 minutes with DNase inhibitor reagent provided in the kit. RNA 
concentration and quality was measured by using a Nanodrop and stored at -80ºC until 
use. 
cDNA generation 
In order to synthesis cDNA from our RNA extracts, we used the High Capacity RNA-to-
cDNA Kit (Applied Biosystems) following manufacturer’s protocol. Briefly, 20µl of the 
extracted RNA was combined with 20µl Reverse transcriptase buffer (RTSB), and 2µl of 
the RTSB Enzyme Mix. Reactions were incubated at 37ºC for 60 minutes followed by 5 
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minutes incubation at 95ºC in a thermocycler. cDNA samples were stored at -20ºC until 
use in PCR reactions. 
 
 
 
 
 
Polymerase Chain Reaction (PCR) 
PCR reactions were conducted following manufactures recommendations, briefly 
TABLE 6: PCR Reaction Using GoTaq® (Promega). 
 
 1 rxn 
5 x buffer 5.000 µl  
dNTP 1.000 µl 
Primer mix 2.000 µl 
Go Taq 0.125 µl 
cDNA 2.000 µl 
ddH2O 14.875 µl 
 
TABLE 7: Primers. Primer utilized in this study. Underlined portions represent 
restriction enzymes.  
 
Primer Name Sequence (5’ à  3’) Tm (ºC) 
BB0170 Forward GTTAAACCGATTCCTGGAGAG 58 
BB0170 Reverse CAGCCAAAACTTGATGCTC 62 
BB0171 Forward CGAGGTGGCTTTCAAAGAAG 45 
BB0171 Reverse TCTCAACCATACAACCCTCTCA 49 
BB0172 Forward GCTTGATTTTTTTAATTTTATCC 45.3 
BB0172 Reverse CGGGATTACTCCCGCCAATCCCAA 63.1 
BB0173 Forward GAAGATGATACATCTTAGTGCTGG 53 
BB0173 Reverse CTTCCCTGATAAAATTTTCCAGAT 51.2 
BB0174-NdeI-F ACGCCATATGATGCCGACTCGTTATTAT 69 
BB0174-XhoI-R ACGCCTCGAGAATGTTAACATTAGCACC  69 
BB0174 Forward CCTGGAACAAGCACCTATTG 50 
BB0174 Reverse CACTTTGATCCCCACCATCT 47 
BB0175 Forward TTTCATGAGTTTAGGCCG 55 
BB0175 Reverse TGTTGACTTGCTAAACCC 52 
BB0176 Forward TTACTTGAAGGGGTTCCG 56 
BB0176 Reverse ATCCCTTTCACGAGATGC 56 
 
  17 
illustrated by TABLE 6. Different primer mixes (TABLE 7) comprising the priming 
Forward and Reverse of each of the genes tested were used. The program used in this 
part of the study was as follows: 94°C for one minute, and 30 cycles of 94ºC for 1 
minute, annealing temperature 55°C for one minute, and polymerization temperature of 
72°C for three minutes. Samples were held at 4ºC until loaded in to a 0.8% agarose gel.  
Quantitative Real Time PCR reaction 
In order to quantify the levels of expression of the different genes studied we carried out 
Real time PCR utilizing the cDNA generated from the RNA extraction obtained after 
growing B. burgdorferi B31 strain under different conditions. To perform the gene 
expression analysis we used customized plates for B. burgdorferi from Lonza 
StellArrayTM Gene expression Arrays. Plates were divided in 3 sets of 32 wells each. 
Each set contains 31 different primer sets (one set per well) to detect the levels of 
expression of the genes outlined in TABLE 8. Briefly, cDNA (400ng/well) was mixed 
with 2xSYBR® Green Master Mix (Aplied Biosystem) and water in order to have a total 
of 20µl/well. One plate was used per cDNA sample (RT vs. 37ºC in duplicate) in order 
to acquire enough data points to compare expression profiles. After loading the plate 
with the PCR master Mix containing the cDNA, plates were centrifuged for 2 minutes at 
500rpms and loaded on an ABI 7500 Real Time PCR thermocycler using the following 
cycler: 
1) One cycle of 50°C for 2 minutes (helps to dissolve primers) 
2) One cycle of 94ºC for 10 minutes 
3) Forty cycles of: 95°C for 15 seconds 60°C for 1 minute 
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4) Dissociation curve (Melt curve)  
Ct values were recorded and utilized in the Global Pattern RecognitionTM Data analysis 
tool offered by Lonza StellArrayTM to determine the expression profile of the genes 
studied.  
TABLE 8: List of Genes. List of genes in the customized StellArrayTM (Lonza) plates 
 
Gene Locus Location Function 
SodA bb0153 Chromosome Superoxide dismutase A (Mn-dependent) 
BosR bb0647 Chromosome Borrelia oxidative stress regulator 
NapA bb0690 Chromosome neutrophil activating protein A 
CsrA bb0184 Chromosome Carbon storage regulator A 
GAPDH bb0057 Chromosome Glycolytic pathway 
RpoN bb0450 Chromosome RNA polymerase Sigma factor (σ-54) 
RpoS bb0771 Chromosome RNA polymerase Sigma factor 
Rrp1 bb0419 Chromosome Response regulator protein 
Hpk1 bb0420 Chromosome Sensory transduction histidine kinase 
OspA bba15 Lp54 Outer surface protein 
OspC bbb19 Cp26 Outer surface protein 
OspF bbr42 Cp32-4 Outer surface protein (renamed as ErpY) 
DbpA/B bba24/bba25 Lp54 Decorin binding proteins A and B 
FlaB bb0147 Chromosome Flagellin subunit (p41) 
BBK32 bbk32 Lp54 Fibronectin binding protein 
BBA34 bba34 Lp54 Bacterial extracellular solute binding protein 
BBA64 bba64 Lp54 Hypothetical protein (antigen P35) 
BBA65 bba65 Lp54 Hypothetical protein 
BBA66 bba66 Lp54 Outer surface protein 
BB0172 bb0172 Chromosome Hypothetical protein ( von Willebrand factor type A domain protein) 
BB0174 bb0174 Chromosome Hypothetical protein  
BB0173 bb0173 Chromosome Hypothetical protein (von Willebrand factor type A domain protein) 
BB0175 bb0175 Chromosome Hypothetical protein 
P66 bb0603 Chromosome Integral outer membrane protein P66 
BB0831 bb0831 Chromosome Xylose operon regulatory protein 
BB0171 bb0171 Chromosome Tetratricopeptide repeat domain protein 
MvaD bb0686 Chromosome Diphosphomevalonate decarboxylase 
BB0687 bb0687 Chromosome Phosphomevalonate kinase, putative 
Mvk bb0688 Chromosome Mevalonate kinase 
XylR1 bb0693 Chromosome Xylose operon regulatory protein  
RecA bbb0131 Chromosome Recombinase A 
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Immunoblot assay 
In order to determine the levels of BB0174 in Borrelia burgdorferi after growing under 
different pH and temperature conditions we ran immunoblot assays. To this end, after 
growing and harvesting cells following the protocol described above, cells were re-
suspended in 50µl of HBSS buffer and lyzed by adding 50µl of the 2xFSB. After boiling 
for 5 minutes, 5µl of the cell lysate were separated on a 12%SDS-PAGE gel. One gel 
was used for coomassie blue staining an another gel was transferred to nitrocellulose 
membranes and blocked overnight at 4ºC in Tris Buffer saline (TBS) containing 0.2% 
Tween 20 and 10% skim milk. After blocking membranes were incubated for 1hr at 
room temperature with 1:1500 dilution of the Chicken anti-BB0174 antibody. After the 
primary antibody incubation, membranes were washed 4 times 5 minutes each with TBS 
containing 0.2% Tween 20 (TBS-T) followed by 1hr incubation at RT in 1:3000 dilution 
of the anti-chicken –HRP conjugated antibody when detecting the rBB0174, and 
1:25,000 dilution of the anti-chicken-HRP conjugated antibody when detecting BB0174 
in Borrelia burgdorferi. After washing 6 times for 5 minutes in TBS-T membranes were 
incubated with ECL detection reagent (GE Healthcare) when detecting rBB0174 and 
with ECL prime detection reagent (GE Healthcare) when detecting BB0174 on B. 
burgdorferi. Membranes were exposed for 30 seconds to 5 minutes on autoradiography 
films and developed in a dark room. 
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CHAPTER III 
 
RESULTS 
 
Cloning bb0174 into pCR®2.1 TOPO® 
After bb0172 was amplified by PCR we confirmed the correct size of the amplicon by 
running a 0.8% agarose gel (figure 3, lane 2). This 900 base pairs amplicon was cloned 
into the cloning vector pCR® TOPO® (Invitrogen) to purify enough DNA to continue 
with the cloning of bb0174 into the expression host. The positive clones were also stored 
at -80ºC for further use. A representative cartoon of this cloning step is outlined in figure 
4A. 
 
 
 
 
Expression of rBB0174 
Cloning of bb0172 in the expression vector pET23a 
After cloning bb0174 into pCR2.1® we were ready to start the cloning of this gene into 
the expressing vector pET23a (Novagen). A cartoon representing the final clone is 
depicted in figure 4B. To this end, we digested both the pET23a vector and the pCR2.1 
 
FIG 3: PCR Amplification of bb0174. Lane 3 shows bb0174 at roughly 900 base 
pairs. 
  21 
(bb0174) construct with, NdeI and XhoI restriction enzymes (New England Biolabs). 
Digestion products were separated in a 0.8% agarose gel as shown in figure 4C. The 
correct bands for digested pET23a and bb0174 were excised from the gel and purified 
using the Promega PCR and gel Clean-up kit and ligated as described in the material and 
methods section. After transforming Top 10 E. coli cells with the ligation products and 
after selecting on Ampicillin plates, positive clones were screened by PCR using primers 
specific for bb0174 and also primers aligning with the T7 promoter and terminators 
present in pET23a clone to verify both, that we have the right insert cloned and that the 
vector is pET23a. This step was necessary since pCR2.1® which also contains 
ampicillin resistance that can contaminate the final ligation product that was used in the 
transformation. After picking the right clones, we stored them at -80ºC for further use. 
Sequencing reaction 
Positive clones for pET23a (bb0174) by restriction enzyme digestion and PCR were 
grown overnight and plasmidic DNA was extracted from each of the clone and were 
submitted for sequencing utilizing specific primers to the T7 Promoter and T7 
Terminator under which bb0174 was cloned in pET23a. With the sequencing reaction 
we found that bb0174 was cloned in frame with the T7 promoter, the six histidines were 
present in frame in the C-terminator end of the protein followed by the T7 terminator. 
With these results we confirmed that bb0174 has been cloned correctly (figure 4). We 
used clone number 10 for expression and purification of recombinant BB0174 protein. 
Sequencing reaction for BB0174 clone #10 using T7-promoter, and T-7 terminator can 
be depicted in figure 5. 
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(A)      (B) 
           
 
 
(C)      (D) 
      
 
 
FIG 4: pCR2.1 TOPO®. Representative cartoons of the cloning of bb0174 in 
pCR2.1 TOPO ® (A) and the expression vector pET23a (B). Cloning of bb0174 
in expression vector pET23a (C). Lane 1 represents digested pET23a with NdeI 
and XhoI enzymes (NEB), lane 2 represents bb0174 cloned in pCR®2.1 and 
digested with the same enzymes (D). PCR amplification reaction to screen for 
positive clones using T7 promoter and terminator primers (lane 1-6) or specific 
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(A) 
 
(B) 
 
FIG 5: Sequencing Reaction for pET23a(bb0174). Utilizing the T7 promoter (A) and T7 
terminator (B) primers. The first 200 nucleotide sequenced are represented. Highlighted in 
yellow, is the His*tag, in green, are the NdeI and XhoI digestion recognition sites and in 
red the starting Met. 
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Expression and purification of rBB0174 
After confirming that the pET23a(bb0174) construct had all the required components in 
frame for optimal expression of BB0174, RosettaTM expression host cells were 
transformed with this construct and small scale inductions were done in order to 
determine how long the induction reaction needs to take so as to get rBB0174 expressed 
in optimal amounts. As shown in figure 6A, two to three hours are enough to induce the 
expression of rBB0174. Larger cultures of pET23a(bb0174) construct in Rosetta were 
started and induced for 2 hours. Cells were harvested and lysated using a French press to 
prevent degradation of the recombinant protein expressed. After the proteins bind to the 
Nickle bead column as described in material and methods, each one of the fractions 
collected was separated in 12% SDS-PAGE gels. As shown in figure 6B, BB0174 was 
present in elution fraction 4 through 10. These fractions were pooled and dialyzed to 
remove the Urea and Imidazol that were present during the purification process. After 
dialysis, the purified protein was concentrated by using the Amicon centrifugation 
system. Proteins were quantified by using the BCA assay giving a concentration ranging 
around 200µg/ml. The clean protein was used to immunized chicken and obtain 
rBB0174 specific IgY that was used in the evaluation of BB0174 levels in B. burgdorferi 
growing at different conditions. 
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Expression of B. burgdorferi B31 genes 
In order to determine under which conditions bb0174 and bb0175 were expressed B. 
burgdorferi B31 strain MSK5 was grown at RT/pH7.6 and 37ºC/pH6.8. As observed in 
FIG 7A PCR reaction using genomic Borrelial DNA and each of the primer sets 
designed for bb0170, bb0171, bb0172, bb0173, bb0174, bb0175, and bb0176 showed an 
amplicon. This confirms that they can be used in the study of the gene expression using 
PCR reaction and cDNA form Borrelia growing under different temperature and pH 
conditions. When analyzing the gene expression in the borrelial sample growing under 
RT conditions, only bb0173, and bb0176 showed any amplification (figure 7B). On the 
(A) 
                   
(B) 
 
 
FIG 6: SDS-Page gel. Mentioned in order of lanes: Marker, lysate, pellet, PASN, Wash 1, Wash 
2, Elutions 1-17.  
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other hand, when analyzing the cultures shifted to 37ºC simulating the tick feeding 
conditions, all genes were expressed except bb0171. This lack of expression could be 
explained by the fact that bb0171 expressing conditions will differ from those used in 
this experiment. Due to the low amplification levels when using the primers for bb0171, 
and bb0174, we decided to design new ones and check whether they were giving better 
amplification yields in the PCR reactions from cDNA obtained from cultures growing at 
37ºC culture. Figure 7D shows that with the new primer sets generated better 
amplification. Another gene that gave some discrepancies in the in vitro gene expression 
study was bb0175, which was amplified in some of the preparations but not in all of 
them (Figure 7D). Figure 7D also shows the absent of amplification when using the 
bb0174-bb0175 primer mix. This primer mix was checking for the presence of an operon 
encoding for BB0174 and BB0175. This result suggest the absence of an operon in this 
region, even though both genes are expressed under the same conditions and are 
regulated by Rrp1 (17). 
 
Furthermore, real time PCR analysis shows that the genes studied in this thesis, are not 
as tightly regulated as expected. In Figure 8 we can see that bb0171, bb0173 and bb0175 
are down regulated when shifted to 37ºC while bb0172 and bb0174 are up regulated 
under the same conditions. In order to validate the data, ospC and flaB genes are used as 
controls, since ospC should be up-regulated at 37ºC and the flaB should not show any 
change based on previous studies. These results suggest that those genes will have to be 
studied in vivo, using the tick model for the transmission of Lyme disease, as has been 
shown for the regulator Rrp1 and Hpk1 (8, 17), which regulates some of those genes.   
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FIG 7: Gene Expression. (A). Positive Primers: Lanes labeled accordingly (lanes 1-8): 
bb0170, bb0171, bb0172, bb0173, bb0174, bb0175, bb0176, negative control. (B). RT 
cDNA: Lanes labeled accordingly (1-9): bb0170, bb0171, bb0172, bb0173, bb0174, bb0175, 
bb0176, negative control, water control. (C). 37ºC cDNA (new): Lanes labeled accordingly; 
bb0170, bb0171, bb0172, bb0173, bb0174, bb0175, bb0176, negative control. (D). 37ºC 
cDNA: Lanes labeled accordingly (1-10): bb0170, bb0171, bb0172, bb0173, bb0174, 
bb0175, bb0176, bb0172-bb0173 primer mix, bb0174-bb0175 primer mix, negative control.  
 
 
 
FIG 8: Real-Time PCR. Gobal pater recognition analysis using Lonza StellArrayTM online 
tools. Bars represent the fold change of gene expression when samples are shifted from RT to 
37ºC.  
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In order to confirm that BB0174 was expressed in Borrelia we also evaluated the 
presence of the protein by immunoblot assay. Figure 9 shows that the IgY generated 
recognized the recombinant BB0174 (FIG.9A) but also, it recognized BB0174 expressed 
in Borrelia burgdorferi only after shifting from RT conditions to 37ºC and pH6.8 which 
mimics the tick feeding conditions (FIG.9B).  
 
FIG 9: Immunoblot Assay of BB0174. (A) E. coli expressing in noninduced 0-
hour in lane 1, induced 0-hour in lane 2.  Lane 3 depicts induced at 3-hour, and 
noninduced at 3-hour. (B) Detection of BB0174 in Bb growing in different 
conditions, Lane 1 is at RT pH7.6, and lane 2 shifted to 37ºC at pH6.8. 
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CHAPTER IV 
 
SUMMARY AND CONCLUSIONS 
 
The ability of Borrelia burgdorferi to colonize the mammalian host is dependent on its 
ability to rapidly alter gene expression in response to highly disparate environmental 
signals following transmission from infected ticks. This type of response is very much 
dependent on the presence of a robust signal transduction system that can induce change 
in gene expression (9, 12). In bacteria, the signal transduction relays on Two-component 
systems (TCS) (9). TCS typically consist of a membrane associated histidine kinase 
(HK) and a response regulator (RR) (19). Our understanding of the role of TCS play in 
the biology of B. burgdorferi is limited, but have begun to slowly identify some of the 
key components as well as the effector molecules (6, 8, 10, 11, 17, 19, 20). 
B.burgdorferi harbours two TCS comprised by the histidine kinate 1 (HK1, bb0420) and 
response regulartor 1 Rrp1 (bb0419) (6, 17) and the Hk2 (bb0764) and the Rrp2 
(bb0763) (3, 4, 15, 21, 25). We know understand that the Rrp2 sigma factor pathway in 
which Rrp2 will activate the expression of RpoN and this one will regulate the 
expression of RpoS wich will directly regulate the expression of a number of proteins in 
B. burgdorferi that will allow the survival of the bacteria in the mammalian host (3, 4, 
15, 16, 21, 25). On the other hand, the Hk1-Rrp1 TCS has been recently studied and 
research shows that this pathway uses the cyclic di-GMP as the signal transduction 
molecule in Borrelia (6, 10, 11, 17, 19). These two component systems have been shown 
to regulate a significant number of genes, and it has been proben that the Hk1-Rrp1 
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system is essential to orchestrate the genes responsible for the survival of B. burgdorferi 
in the tick vector (6, 11) while the Hk2-Rrp2 is essential for the survival of the bacteria 
in the mammalian host (4, 5, 21, 25). Eventhough some advances have been made in this 
field, many more TCS have been described in other bacterial pathogens (9). Therefore, 
further studies are needed in this regard. After analyzing the genes in B. burgdorferi that 
are regulated by Rrp1, we observed that one of the, bb0174 protein  had all the domains 
required to be a membrane sensor with a signal peptide, a transmembrane domain in the 
center of the protein with an intracellular C-terminus domain with a potential 
autophosphorilation site (InterPro online analysis). Since there are not many sensors 
described to date in this spirochaetal species, we hypothesized that due to the in silico 
domain prediction., BB0174 could be a sensor candidate and could be the HK 
component of the TCS. When looking at the neighboring genes we realized that bb0175 
was encoding for a protein that by in silico prediction was intracellular and had a number 
phosphorilation sites. Therefore, we hypothetise that this two proteins could be part of 
another sensoring pathway that B. burgdorferi could use to feel change in environmental 
conditions. Both of those proteins are annotated as hypothetical proteins so our study 
iniciated by the cloning and production of recombinant BB0174 to use in the generation 
of specific antibodies that will allow us to unveil where and when this protein is 
expressed and whether or not it will be part of a novel TCS or will be a member of those 
already described in this zoonotic pathogen.   
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In order to determine the expression of bb0174 in in vitro conditions, total RNA was 
purified from Borrelia growing at different conditions (RT vs 37ºC). After RNA was 
isolated cDNA was generated and PCR was performed using the primer sets described in 
TABLE 7. Our PCR analysis show that bb0174 was expressed when shifting the bacteria 
from unfed (RT/pH7.6) to fed (37ºC/pH6.8) tick conditions. Moreover this results are in 
accordance with the immunolobot analysis performed in this thesis, in which BB0174 
levels are undetectable when the bacterium is growing under unfed tick conditions, and 
increases to detectable levels when the bacterium is shifted to the fed tick conditions. In 
addition to these qualitative analysis we also performed real time PCR analysis of the 
levels of mRNA of bb0174 and other genes in the same chromosomal area that are 
regulated by the same HK1-Rrp1 TCS (17). Conidering the fact that Rrp1 is a repressor 
of bb0170, bb0173, bb0174 and bb0175, when its levels are reduced, those of the 
repressed genes should inrease (17, 6). Consequently when doing the RT-PCR analysis, 
we observed that the Rrp1 gene was downregulated upon transition from the unfed tick 
to the fed tick-mammalian host conditions. At the same time bb0174 was upregulated 
but not the bb0175 gene. These results suggest that, in vitro conditions are not optimal 
for the study of the expression of these genes, and as observed by Rodgers et al (17, 6) 
they have to be studied in the tick model of Lyme disease. Moreover this observation is 
showing that there is no operon comprising bb0174-bb0175 as suggested by the PCR 
results using cDNA and in contrast with the in silico analysis.  
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In silico analysis of the bb0174 sequence suggest that is could be an aerotolarance 
receptor.This type of protein will be of great advantage for B. burgdorferi to sense the 
levels of oxygen in the environment surronding this bacteriu,, and could be of 
importance for itssurvival in a microaerobic millieu. In order to test this hypothesis more 
studies will be done in the tick model as well as in vitro under anaerobic and 
microaerofilic conditions.  
 
Taken together, out studies showed that bb0174-bb0175 are not part of a new Two 
component system and that both are expressed under growth conditions that mimic the 
fed tick conditions (37ºC/pH6.8). In addition we have been able to express and purify 
recombinatn BB0174 that have been used in the generation of specific antibodies in 
laying hens. This protocol is very advantageous since we can generate a large amount of 
antibodies in the egg yolk and we avoide the euthanization of animals for research 
porposes.  
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